Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction

Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction

<i>Background and Objectives:</i> Tadalafil is expected to treat fetal growth restriction (FGR), a risk factor for stillbirth and neonatal morbidity. This study aimed to evaluate the fetal biometric growth pattern of fetuses with FGR treated with tadalafil by ultrasonographic assessment....

Full description

Bibliographic Details
Main Authors: Makoto Tsuji, Shintaro Maki, Naosuke Enomoto, Kota Okamoto, Asa Kitamura, Shoichi Magawa, Sho Takakura, Masafumi Nii, Kayo Tanaka, Noriko Yodoya, Hiroaki Tanaka, Hirofumi Sawada, Eiji Kondo, Masahiro Hirayama, Tomoaki Ikeda
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Medicina
Subjects:
tadalafil
fetal growth restriction
fetal biometric assessment
fetal head circumference
brain-sparing effect
Online Access:https://www.mdpi.com/1648-9144/59/5/900

Internet

https://www.mdpi.com/1648-9144/59/5/900

Similar Items